• Publications
  • Influence
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 *
The Zar Review Group: I.J. Bousquet, N. Khaltaev, A. R. Rabe, J. Rosado-Pinto, G. Scadding, F. Simons, E. Togias, T. Valovirta, P. Vandenplas, D. Wang, M. Stoloff, O. Williams.
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.
All available evidence for management of acute and chronic rhinosinusitis with or without nasal polyps in adults and children is analyzed and presented and management schemes based on the evidence are proposed.
Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation.
The significance of mitochondrial DAMPs is highlighted and their contribution to inflammation and development of human pathologies is discussed.
Rhinosinusitis: Establishing definitions for clinical research and patient care
An expert panel from multiple disciplines developed definitions for rhinosinusitis and outlined strategies for design of clinical trials and reached consensus on definitions and strategies for clinical research on acute presumed bacterial rhinosineitis, chronic rhinosinitis with polyposis, and classic allergic fungal rhinusitis.
Practical guide to skin prick tests in allergy to aeroallergens
The Practical guide to skin prick tests in allergy to aeroallergens 2012; 67: 18–24 is cited.
European Position Paper on Rhinosinusitis and Nasal Polyps 2020.
The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012 and addresses areas not extensively covered in EPOS2012 such as paediatric CRS and sinus surgery.
Chronic rhinosinusitis in Europe – an underestimated disease. A GA2LEN study
This data indicates that rhinosinusitis in Europe is an underestimated disease, and the number of patients diagnosed with the disease and the severity of the disease should be increased.
EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity
Abstract:  Aspirin and other nonsteroidal anti‐inflammatory drugs (NSAIDs) are among the most common causes of adverse drug reactions. Majority of them are of the hypersensitivity type. The two
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis.
Mepolizumab achieved a statistically significant reduction in NP size for at least 1 month after dosing in 12 of 20 patients, indicating IL-5 inhibition is a potential novel therapeutic approach in patients with severe eosinophilic nasal polyposis.